Title: Role of Polymers in Ternary Drug Cyclodextrin Complexes
Abstract: Chapter 12 Role of Polymers in Ternary Drug Cyclodextrin Complexes Renu Chadha, Renu Chadha [email protected] Search for more papers by this authorMadhu Bala, Madhu BalaSearch for more papers by this authorParnika Goyal, Parnika GoyalSearch for more papers by this authorKunal Chadha, Kunal ChadhaSearch for more papers by this authorManinder Karan, Maninder KaranSearch for more papers by this author Renu Chadha, Renu Chadha [email protected] Search for more papers by this authorMadhu Bala, Madhu BalaSearch for more papers by this authorParnika Goyal, Parnika GoyalSearch for more papers by this authorKunal Chadha, Kunal ChadhaSearch for more papers by this authorManinder Karan, Maninder KaranSearch for more papers by this author Book Editor(s):Vijay Kumar Thakur, Vijay Kumar ThakurSearch for more papers by this authorManju Kumari Thakur, Manju Kumari ThakurSearch for more papers by this author First published: 19 September 2015 https://doi.org/10.1002/9781119041450.ch12Citations: 1 AboutPDFPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShareShare a linkShare onEmailFacebookTwitterLinkedInRedditWechat Summary This chapter contains sections titled: Introduction Cyclodextrins (Cycloamyloses, Cyclomaltoses, Schardinger Dextrins) Role of Biodegradable/Water-Soluble Polymers in Efficacy of Inclusion Complexes Solubility, Dissolution and Bioavailability Enhancement: Case Studies Conclusion References M. Bauser, and H. Stakemeier, Instrumentation for combinatorial chemistry. Handbook of Combinatorial Chemistry, vol. 1, pp. 190–224, 2002. Google Scholar F. Balkenhohl, C. von dem Bussche-Huennefeld, A. Lansky, and C. Zechel, Combinatorial synthesis of small organic molecules. Angew. Chem., Int. Ed. Engl., 35 (20), 2288–2337, 1996. 10.1002/anie.199622881 CASGoogle Scholar M.N. Martinez, and G.L. Amidon, A mechanistic approach to understanding the factors affecting drug absorption: A review of fundamentals. J. Clin. Pharmacol., 42 (6), 620–643, 2002. 10.1177/00970002042006005 CASPubMedWeb of Science®Google Scholar C.B. Aakeroy, M.E. Fasulo, and J. Desper, Cocrystal or salt: Does it really matter?. Mol. Pharm., 4, 317–22, 2007. 10.1021/mp060126o CASPubMedWeb of Science®Google Scholar G.L. Amidon, A theoretical basis for a biopharmaceutic drug classification: The correlation of in vivo drug product dissolution and in vivo bioavalability. Pharm. Res., 12 (3), 413–420, 1995. 10.1023/A:1016212804288 CASPubMedWeb of Science®Google Scholar T. Loftsson, and M.E. Brewster, Pharmaceutical applications of cyclodextrins. 1: Drug solubilization and stabilization. J. Pharm. Sci., 85, 1017–1025, 1996. 10.1021/js950534b CASPubMedWeb of Science®Google Scholar W. Marie, and A. Maggie, Solid state studies of drug–cyclodextrin inclusion complexes in PEG 6000 prepared by a new method. Eur. J. Pharm. Sci., 8 (4), 269–281, 1999. 10.1016/S0928-0987(99)00020-2 PubMedWeb of Science®Google Scholar C.R. Dass, and W. Jessup, Apolipoprotiens A-I. Cyclodextrins and liposomes as potential drugs for the reversal of atherosclerosis. J. Pharm. Pharmacol., 52, 731–61, 2000. 10.1211/0022357001774606 CASPubMedWeb of Science®Google Scholar S. Ramnik, B. Nitin, M. Jyotsana Madan, and S.N. Hiremath, Characterization of cyclodextrin inclusion complexes – A Review. J. Pharm. Sci. Tech., 2 (3), 171–183, 2010. Google Scholar E.M. Martin Del Valle, Cyclodextrins and their uses: A review. Process Biochem., 39, 1033–1046, 2004. 10.1016/S0032-9592(03)00258-9 CASWeb of Science®Google Scholar Chromatography Online, Chrial-GC - Cyclodextrin chiral stationary phases from chrial gas chromatography, http://www.chromatography-online.org/Chrial-GC/Contemporary-Chiral-Stationary-Phases/Cyclodextrin.php. Google Scholar W. Saenger, Cyclodextrin inclusion compounds in research and industry. Angew. Chem. Int. Ed. Engl., 19, 344–362, 1980. 10.1002/anie.198003441 Web of Science®Google Scholar S. Muñoz-Botella, B. Del Castillo, M.A. Martyn, Cyclodextrin properties and applications of inclusion complex formation. Ars. Pharm., 36, 187–98, 1995. CASGoogle Scholar E. Schneiderman, and A.M. Stalcup, Cyclodextrins: A versatile tool in separation science. J. Chromatogr. B, 745, 83–102, 2000. 10.1016/S0378-4347(00)00057-8 CASPubMedWeb of Science®Google Scholar J. Szetjli, Introduction and general overview of cyclodextrin chemistry. Chem. Rev., 98, 1743–53, 1998. 10.1021/cr970022c PubMedWeb of Science®Google Scholar T. Loftsson, and M. Masson, The effects of water-soluble polymers on cyclodextrins and cyclodextrin solubilization of drugs. J. Drug Del. Sci. Tech., 14 (1), 35–43, 2004. 10.1016/S1773-2247(04)50003-5 CASWeb of Science®Google Scholar T. Loftsson, Increasing the cyclodextrin complexation of drugs and drug biovailability through addition of water-soluble polymers. Pharmazie, 53, 733–740, 1998. CASPubMedWeb of Science®Google Scholar M. Lahiani-Skiba, C. Barbot, F. Bounoure, S. Joudieh, and M. Skiba, Solubility and dissolution rate of progesterone-cyclodextrin-polymer systems. Drug Dev. Ind. Pharm., 32, 1043–1058, 2006. 10.1080/03639040600897093 CASPubMedWeb of Science®Google Scholar F. Veiga, C. Pecorelli, and L. Ribeiro, As Ciclodextrinas em Tecnologia Farmacêutica, Coimbra: Minerva Coimbra, pp. 9–33, 2006. Google Scholar T. Loftsson, K. Matthfasson, and M. Masson, The effects of organic salts on the cyclodextrin solubilization of drugs. Int. J. Pharm., 262 (1–2), 101–107, 2003. 10.1016/S0378-5173(03)00334-X CASPubMedWeb of Science®Google Scholar C. Alvarez., T. Van Hees, G. Piel, J.F. Legeois, L. Delattre, and B. Evrard, Preparation of mebendazole-hydroxypropyl-β-cyclodextrin complexes using water-soluble polymers and organic salts. STP Pharma Sci, 11, 439–442, 2001. Web of Science®Google Scholar T. Yamakawa, and S. Nishimura, Liquid formulation of a novel non-fluorinated topical quinolone, T-3912, utilizing the synergic solubilizing effect of the combined use of magnesium ions and hydroxypropyl-β-cyclodextrin. J. Cont. ReI., 86, 101–113, 2003. 10.1016/S0168-3659(02)00367-X CASPubMedWeb of Science®Google Scholar P. Augustijns, J. Brouwers, and M.E. Brewster, Supersaturating drug delivery systems: The answer to solubility-limited oral bioavailability?. J. Pharm. Sci., 98, 2549–2572, 2009. 10.1002/jps.21650 CASPubMedWeb of Science®Google Scholar T. Taupitz, J.B. Dressman, C.M. Buchanan, and S. Klein, Cyclodextrin-water soluble polymer ternary complexes enhance the solubility and dissolution behaviour of poorly soluble drugs. Case example: Itraconazole. Eur. J. Pharm. Biopharm., 83, 378–387, 2013. 10.1016/j.ejpb.2012.11.003 CASPubMedWeb of Science®Google Scholar P. Mura, M.T. Faucci, and G.P. Bettinetti, The influence of polyvinylpyrrolidone on naproxen complexation with hydroxypropyl-β-cyclodextrin. Eur. J. Pharm. Sci., 13, 187–194, 2001. 10.1016/S0928-0987(01)00093-8 CASPubMedWeb of Science®Google Scholar B. Pose-Vilarnovo, T.S.C. Rodriguez, M.B. Perez-Marcos, and J.J. Torres-Labandeira, Sulphamethoxazole-cyclodextrin-hydroxy propyl methylcellulose multicomponent complexes. J. Therm. Anal. Cal., 68, 657–667, 2002. 10.1023/A:1016016525607 CASWeb of Science®Google Scholar E. Redenti, L. Szente, and J. Szejtli, Cyclodextrin complexes of salts of acidic drugs. Thermodynamic properties, structural features, and pharmaceutical applications. J. Pharm. Sci., 90, 979–986, 2001. 10.1002/jps.1050 CASPubMedWeb of Science®Google Scholar T. Loftsson, and N. Bodor, Effects of 2-hydroxypropyl-β-cyclodextrin on the aqueous solubility of drugs and transdermal delivery of 17β-estradiol. Acta Pharm. Nord., 1, 185–193, 1989. CASPubMedWeb of Science®Google Scholar R. Krishnamoorthy, and A.K. Mitra, Complexation of weak acids and basis with cyclodextrins: Effects of substrate ionization on the estimation and interpretation of association constants. Int. J. Pharm. Adv., 1, 330–343, 1996. Google Scholar T. Loftsson, M. Masson, and J.F. Sigurjonsdottir, Methods to enhance the complexation efficiency of cyclodextrins. STP Pharma. Sci., 9, 237–242, 1999. CASWeb of Science®Google Scholar T. Loftsson, K. Guomundsdottirt, and H. Frloriksdottir, The influence of water-soluble polymers and pH on hydroxypropyl-β-cyclodextrin complexation of drugs. Drug Dev. Ind. Pharm., 22, 401–405, 1996. 10.3109/03639049609069348 CASWeb of Science®Google Scholar A. Harada, Design and construction of supramolecular architectures consisting of cyclodextrins and polymers. Adv. Pol. Sci., 133, 141–191, 1997. 10.1007/3-540-68442-5_4 Web of Science®Google Scholar T. Hladon, and B. Cwiternia, Physical and chemical interactions between cellulose ethers and β-cyclodextrins. Pharmazie, 49, 497–500, 1994. CASWeb of Science®Google Scholar M. Valero, B.I. Revuelta, and L.J. Rodriguez, Effect of PVP K-25 on the formation of the naproxen:beta-cyclodextrin complex. Int. J. Pharm., 253, 97–110, 2003. 10.1016/S0378-5173(02)00664-6 CASPubMedWeb of Science®Google Scholar L. Ribeiro, and F. Veiga, Complexation of vinpocetine with cyclodextrins in the presence or absence of polymers. Binary and ternary complexes preparation and characterization. J. Incl. Phenom. Macrocycl. Chem., 44, 251–256, 2002. 10.1023/A:1023069609303 CASWeb of Science®Google Scholar T. Loftsson, Cyclodextrin complexation U.S. Patent 5472954, Iceland, Cyclops h.f. 1995. Google Scholar J. Szeman, E. Fenyvesi, and J. Szejtli, Water soluble cyclodextrin polymers: their interaction with drugs. J. Incl. Phenom. Macrocycl. Chem., 5, 427–431, 1987. 10.1007/BF00664098 CASWeb of Science®Google Scholar J. Szeman, H. Ueda, J. Szejtli, E. Fenyvesi, Y. Machida, and T. Nagai, Complexation of several drugs with water-soluble cyclodextrin polymer. Chem. Pharm. Bull., 35, 282–288, 1987. 10.1248/cpb.35.282 CASPubMedWeb of Science®Google Scholar E. Fenyvesi, Cyclodextrin polymers in pharmaceutical industry. J. Incl. Phenom. Macrocycl. Chem., 6, 537–545, 1988. 10.1007/BF00660751 CASWeb of Science®Google Scholar E. Fenyvesi, A. Ujhazy, J. Szejtli, S. Putter, and T.G. Gan, Controlled release of drugs from CD polymers substituted with ionic groups. J. Incl. Phenom. Macrocycl. Chem., 25, 185–189, 1996. 10.1007/BF01041566 CASWeb of Science®Google Scholar G. Mocanu, D. Vizitiu, and A. Carpov, Cyclodextrin polymers. J. Bioact. Compat. Pol., 16, 315–342, 2001. 10.1106/JJUV-8F2K-JGYF-HNGF CASWeb of Science®Google Scholar M. Ma, and Q.D. Li, New organic nanoporous polymers and their inclusion complexes. Chem. Mater., 11, 872–874, 1999. 10.1021/cm981090y CASWeb of Science®Google Scholar F. Kihara, H. Arima, T. Tsutsumi, F. Hirayama, and K. Uekama, Effects of structure of polyamidoamine dendrimer on gene transfer efficiency of the dendrimer conjugate with α-cyclodextrin. Bioconjug. Chem., 13, 1211–1219, 2002. 10.1021/bc025557d CASPubMedWeb of Science®Google Scholar H. Asanuma, M. Kakazu, M. Shibata, T. Hishiya, and M. Komiyama, Molecularly imprinted polymer of cyclodextrin for the efficient recognition of cholesterol. Chem. Commun., 1971–1972, 1997. Google Scholar H. Gonzalez, S.J. Hwang, and M.E. Davis, New class of polymers for the delivery of macromolecular therapeutics. Bioconjug. Chem., 10, 1068–1074, 1999. 10.1021/bc990072j CASPubMedWeb of Science®Google Scholar M.E. Davis, S.H. Pun, N.C. Bellocq, T.M. Reineke, S.R. Popielarski, S. Mishra, and J.D. Heidel, Self-assembling nucleic acid delivery vehicles via linear, water soluble, cyclodextrin-containing polymers. Curr. Med. Chem., 11, 1241–1253, 2004. 10.2174/0929867043456179 Web of Science®Google Scholar D. Duchene, C. Vaution, and F. Glomot, Cyclodextrin, their value in pharmaceutical technology. Drug Dev. Ind. Pharm., 12, 2193–2215, 1988. 10.3109/03639048609042630 Web of Science®Google Scholar J. Manosroi, M.G. Apriyani, K. Foe, and A. Manosroi, Enhancement of the release of Azelaic acid through the synthetic membranes by inclusion complex formation with hydroxypropyl-β-cyclodextrin. Int. J. Pharm., 293, 235–240, 2005. 10.1016/j.ijpharm.2005.01.009 CASPubMedWeb of Science®Google Scholar D. Amididouche, H. Darrouzet, D. Duchene, and M.C. Poelman, Inclusion of Retinoic acid in β-cyclodextrin. Int. J. Pharm., 54 (2), 175–179, 1989. 10.1016/0378-5173(89)90338-4 Google Scholar V.R. Sinha, R. Anitha, S. Ghosh, A. Nanda, and R. Kumria, Complexation of Celecoxib with ß-cyclodextrin: Characterization of the interaction in solution and in solid state. J. Pharm. Sci., 94 (3), 676–687, 2005. 10.1002/jps.20287 CASPubMedWeb of Science®Google Scholar H.O. Ammar, H.A. Salama, M. Ghorab, and A.A. Mahmoud, Formulation and biological evaluation of Glimepiride–cyclodextrin– polymer systems. Int. J. Pharm., 309, 129–138, 2006. 10.1016/j.ijpharm.2005.11.024 CASPubMedWeb of Science®Google Scholar G.S. Jadhav, and P.R. Vavia, Physicochemical, in silico and in vivo evaluation of a Danazol-β-cyclodextrin complex. Int. J. Pharm., 352, 5–16, 2008. 10.1016/j.ijpharm.2007.10.005 CASPubMedWeb of Science®Google Scholar P.T. Tayade, and P.R. Vavia, Inclusion complexes of Ketoprofen with β-cyclodextrins: Oral pharmacokinetics of Ketoprofen in human. Indian J. Pharm. Sci., 68 (2), 164–170, 2006. 10.4103/0250-474X.25709 CASGoogle Scholar K. Uekama, K. Oh, T. Irie, M. Otagiri, Y. Nishimiya, and T. Nara, Stabilization of Isosorbide 5-mononitrate in solid state by β-cyclodextrin complexation. Int. J. Pharm., 25 (3), 339–346, 1985. 10.1016/0378-5173(85)90173-5 CASWeb of Science®Google Scholar O. Bekers, E.V. Uijtendaal, J.H. Beijnen, A. Bult, and W.J.M. Underberg, Cyclodextrins in the pharmaceutical field. Drug Dev. Ind. Pharm., 17 (11), 1503–1549, 1991. 10.3109/03639049109026630 CASWeb of Science®Google Scholar K.S. Aithal, N. Udupa, and K.K. Sreenivassan, Physicochemical properties of drug-cyclodextrin complexes. Indian Drugs, 32 (7), 293–305, 1995. Google Scholar B.P. Rao, S. Sarasija, and C. Narendra, Physicochemical characterization of Hydroxypropyl-β-cyclodextrin complexes of Rifampicin for improved anti-tubercular activity and stability. Indian Drugs., 43 (8), 679–682, 2006. Google Scholar A. Bernini, O. Spiga, A. Ciutti, M. Scarseeli, G. Bottoni, P. Mascagni, and N. Niccolai, Corrigendum to NMR studies of the inclusion complex between β-cyclodextrin and Paroxetine. Eur. J. Pharm. Sci., 28 (5), 441, 2006. 10.1016/j.ejps.2005.04.021 CASWeb of Science®Google Scholar M.S. Duan, N. Zhao, I.B. Ossurardottir, T. Thorsteinn, and T. Loftsson, Cyclodextrin solubilization of the antibacterial agents triclosan and triclocarban: Formation of aggregates and higher-order complexes. Int. J. Pharm., 297, 213–222, 2005. 10.1016/j.ijpharm.2005.04.007 CASPubMedWeb of Science®Google Scholar D.D. Chow, and A.K. Karara, Characterization, dissolution and bioavailabilty in rats of Ibuprofen-β-cyclodextrin complex system. Int. J. Pharm., 28, 95–101, 1986. 10.1016/0378-5173(86)90232-2 CASWeb of Science®Google Scholar N. Rajagopalan, S.C. Chen, and W.S. Chow, A study of the inclusion complex of amphotericin-B with γ-cyclodextrin. Int. J. Pharm., 29, 161–168, 1986. 10.1016/0378-5173(86)90113-4 CASWeb of Science®Google Scholar K. Uekama, S. Narisawa, F. Hirayama, and A. Otagiri, Improvement of dissolution and absorption characteristics of benzodiazepines by cyclodextrin complexation. Int. J. Pharm., 16 (3), 327–338, 1983. 10.1016/0378-5173(83)90151-5 CASWeb of Science®Google Scholar T.X. Xiang, and B.D. Andersoon, Inclusion complexes of purine nucleosides with cyclodextrins: II. Investigation of inclusion complex geometry and cavity microenvironment. Int. J. Pharm., 59 (1), 45–55, 1990. 10.1016/0378-5173(90)90063-A CASWeb of Science®Google Scholar A.I.R. Perez, C.R. Tenreiro, C.A. Lorenzo, P. Taboada, A. Concheiro, and J.J.T. Labandeira, Sertaconazole/hydroxypropyl-ß-cyclodextrin complexation: Isothermal titration calorimetry and solubility approaches. J. Pharm. Sci., 95 (8), 1751–1762, 2006. 10.1002/jps.20661 CASPubMedWeb of Science®Google Scholar R. Chadha, S. Gupta, N. Pathak, G. Shukla, D.S. Jain, R.R.S. Pissurlenkar, and E.C. Coutinho, Binary and ternary complexes of Arteether β-CD—characterization, molecular modeling and in vivo studies. Pharmacol. Pharm., 2, 212–225, 2011. 10.4236/pp.2011.23030 CASGoogle Scholar L.J. Soares-Sobrinho, F.L.A. Santos, M.A.M. Lyra, L.D.S. Alves, L.A. Rolim, A.A.N. Lima, L.C.C. Nunes, M.F.R. Soaresa, P.J. Rolim-Neto, annnznidazole drug delivery by binary and multicomponent inclusion complexes using cyclodextrins and polymers. Carb. Pol., 89 (2), 323–30, 2012. 10.1016/j.carbpol.2012.02.042 CASWeb of Science®Google Scholar K.P.R. Chowdary, and S.V. Srinivas, Influence of hydrophilic polymers on celecoxib complexation with hydroxypropyl-β-cyclodextrin. AAPS PharmSciTech, 7 (3), E1–E6, 2006. 10.1208/pt070379 PubMedGoogle Scholar B. Cappello, C. di Maio, M. Iervolino, and A. Miro, Combined effect of hydroxypropyl methylcellulose and hydroxypropyl-β-cyclodextrin on physicochemical and dissolution properties of celecoxib. J. Incl. Phenom. Macrocycl. Chem., 59, 237–244, 2007. 10.1007/s10847-007-9319-y CASWeb of Science®Google Scholar G.S. Borghetti, A.P. Pinto, I.S. Lula, R.D. Sinisterra, H.F. Teixeira, and V.L. Bassani, Daidzein/cyclodextrin/hydrophilic polymer ternary systems. Drug Dev. Ind. Pharm., 37 (8), 886–893, 2007. 10.3109/03639045.2010.548066 CASWeb of Science®Google Scholar R. Chadha, P. Arora, S. Bhandari, and D.V.S. Jain, Effect of hydrophilic polymer on complexing efficiency of cyclodextrins towards efavirenz-characterization and thermodynamic parameters. J. Incl. Phenom. Macrocycl. Chem., 72, 275–287, 2012. 10.1007/s10847-011-9972-z CASWeb of Science®Google Scholar A.C.C. Asbahr, L. Franco, A. Barison, C.W.P. Silva, H.G. Ferraz, and L.N.C. Rodrigues, Binary and ternary inclusion complexes of finasteride in HP-β-CD and polymers: Preparation and characterization. Bioorg. Med. Chem., 17, 2718–2723, 2009. 10.1016/j.bmc.2009.02.044 CASPubMedWeb of Science®Google Scholar H.O. Ammar, H.A. Salama, M. Ghorab, and A.A. Mahmoud, Inclusion complexation of glimipride in dimethyl-β-cyclodextrin. Asian J. Pharm. Sci., 2 (2), 44–55, 2007. Google Scholar R.S. Hirlekar, S.N. Sonawane, and V.J. Kadam, Studies on the effect of water-soluble polymers on drug-cyclodextrin complex solubility. AAPS Pharm. Sci. Tech., 10 (3), 858–863, 2009. 10.1208/s12249-009-9274-6 PubMedWeb of Science®Google Scholar M. Valero, J. Tejedor, and L.J. Rodríguez, Encapsulation of nabumetone by means of -drug: (β-cyclodextrin)2:polyvinylpyrrolidone ternary complex formation. J. Lumin., 126, 297–302, 2007. 10.1016/j.jlumin.2006.07.028 CASWeb of Science®Google Scholar P. Mura, M.T. Faucci, and G.P. Bettinetti, The influence of polyvinylpyrrolidone on naproxen complexation with hydroxypropyl-β-cyclodextrin. Eur. J. Pharm. Sci., 13, 187–194, 2001. 10.1016/S0928-0987(01)00093-8 CASPubMedWeb of Science®Google Scholar A.A. Elbary, M.A. Kassem, M.M. Abou Samra, and R.M. Khalil, Formulation and hypoglycaemic activity of pioglitazone-cyclodextrin inclusion complexes. Drug Discov. Ther., 2 (2), 94–107, 2008. PubMedGoogle Scholar M.L. Skiba, C. Barbot, F. Bounoure, S. Joudieh, and M. Skibav, Solubility and dissolution rate of progesterone-cyclodextrin-polymer systems. Drug Dev. Ind. Pharm., 32, 1043–1058, 2006. 10.1080/03639040600897093 CASPubMedWeb of Science®Google Scholar L.N.C. Rodrigues, M.G. Issa, A.C.C. Asbahr, M.A.C. Silva, and H.G. Ferraz, Multicomponent complex formation between pyrimethamine, cyclodextrins and water- soluble polymers. Braz. Arch. Biol. Technol., 54 (5), 965–972, 2011. 10.1590/S1516-89132011000500014 CASWeb of Science®Google Scholar B. Cappello, C. Carmignani, M. Iervolino, M.I. La Rotonda, and M.F. Saettone, Solubilization of tropicamide by hydroxypropyl-beta-cyclodextrin and water-soluble polymers: In vitro/in vivo studies. Int. J. Pharm., 213 (1–2), 75–81, 2001. 10.1016/S0378-5173(00)00648-7 PubMedWeb of Science®Google Scholar L. Ribeiro, T. Loftsson, D. Ferreira, and F. Veiga, Investigation and physicochemical characterization of vinpocetine-sulfobutyl ether β-cyclodextrin binary and ternary complexes. Chem. Pharm. Bull., 51 (8), 914–922, 2003. 10.1248/cpb.51.914 CASPubMedWeb of Science®Google Scholar J. Jablan, G. Szalontai, and M. Jug, Comparative analysis of zaleplon complexation with cyclodextrins and hydrophilic polymers in solution and in solid state. J. Phar. Biomed. Anal., 71, 35–44, 2012. 10.1016/j.jpba.2012.07.027 CASPubMedWeb of Science®Google Scholar G.P. Bettinetti, P. Mura, A. Liguori, G. Bramanti, and F. Giordano, Solubilization and interaction of naproxen with cyclodextrins in aqueous solution and in the solid state. Farmaco, 44, 195–213, 1989. CASWeb of Science®Google Scholar P. Mura, G.P. Bettinetti, F. Melani, and A. Manderioli, Interaction between naproxen and chemically modified b-cyclodextrins in the liquid and solid state. Eur. J. Pharm. Sci., 3, 347–355, 1995. 10.1016/0928-0987(95)00025-X CASWeb of Science®Google Scholar G.P. Bettinetti, and P. Mura, Dissolution properties of naproxen in combinations with polyvinylpyrrolidone. Drug Dev. Ind. Pharm., 20, 1353–1366, 1994. 10.3109/03639049409038375 CASWeb of Science®Google Scholar H. Fujita, T. Ooya, and M. Kurisawa, Thermally switchable polyrotaxane as a model of stimuli-responsive supramolecules for nano-scale devices. Macromol. Rapid Commun., 17, 509–515, 1996. 10.1002/marc.1996.030170803 CASWeb of Science®Google Scholar T. Loftson, and M.E. Brewster, Cyclodextrins as pharmaceutical excipients. Pharm. Technol. Eu., 9, 26–34, 1997. Google Scholar R. Chadha, M. Bala, P. Arora, D.V.S. Jain, R.R.S. Pissurlenkar, and E.C. Coutinho, Valsartan inclusion by methyl-β-cyclodextrin: Thermodynamics, molecular modelling, Tween 80 effect and evaluation. Carb. Pol., 103, 300–309, 2014. 10.1016/j.carbpol.2013.12.047 CASPubMedWeb of Science®Google Scholar Citing Literature Handbook of Polymers for Pharmaceutical Technologies: Biodegradable Polymers, Volume 3 ReferencesRelatedInformation
Publication Year: 2015
Publication Date: 2015-09-19
Language: en
Type: other
Indexed In: ['crossref']
Access and Citation
Cited By Count: 1
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot